Transarterial Microembolization in Refractory Plantar Fasciitis: Functional and Patient-Reported Early- to Midterm Outcomes from a Single-Center Pilot Study
Diagnostics · 16.07.2026 · 16 (14) · 2217
DOI: 10.3390/diagnostics16142217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 16.07.2026. Verfasst von Hüseyin Saygin Tuna und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, HELIOS University Hospital Wuppertal, University of Witten/Herdecke, Heusnerstr. 40, 42283 Wuppertal, Germany. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Chronic plantar fasciitis refractory to conservative treatment remains a therapeutic challenge, and minimally invasive options targeting pathologic neovascularization are of growing interest. We evaluated the safety and early- to midterm clinical outcomes of transarterial microembolization in refractory plantar fasciitis, with emphasis on functional and patient-reported outcomes.
Methods
In this single-center observational pilot study with ambispective data collection, 16 procedures in 13 patients were treated using imipenem/cilastatin. The primary outcome was pain intensity (Numeric Rating Scale, NRS); secondary outcomes included the Foot Function Index (FFI), the Patient Global Impression of Change (PGIC), analgesic use, return to activity, need for further treatment, and complications.
Results
Technical success was 100%. Median NRS decreased from 10.0 at baseline to 3.0 at 1 month and 0.0 at 3 months, with significant improvement maintained through 18 months. Median FFI improved from 9.42 to near zero, and analgesic use declined. At 12 months, 90.9% of procedures reported clinical improvement. Reintervention was required once (6.3%); only minor complications occurred (12.5%), with no major events. Full return to normal activity was achieved in 68.8%.
Conclusions
Transarterial microembolization was associated with rapid functional and patient-reported improvement and a favorable safety profile. These exploratory, hypothesis-generating findings warrant confirmation in controlled prospective studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, HELIOS University Hospital Wuppertal, University of Witten/Herdecke, Heusnerstr. 40, 42283 Wuppertal, Germany.
- Department of Interventional Radiology and Neuroradiology, Hochsauerland Hospital, Nordring 37-41, 59821 Arnsberg, Germany.
- Department of Interventional Radiology, Faculty of Medicine, Eskisehir Osmangazi University, Buyukdere Meselik Yerleskesi, 26040 Eskisehir, Turkey.
ORCID-Profile: Hüseyin Saygin Tuna
Zitieren
APA
Tuna, H. S., Reichardt, B., Kucukay, F., & Haage, P. (2026). Transarterial Microembolization in Refractory Plantar Fasciitis: Functional and Patient-Reported Early- to Midterm Outcomes from a Single-Center Pilot Study. Diagnostics, 16(14), 2217. https://doi.org/10.3390/diagnostics16142217
Vancouver
Tuna HS, Reichardt B, Kucukay F, Haage P. Transarterial Microembolization in Refractory Plantar Fasciitis: Functional and Patient-Reported Early- to Midterm Outcomes from a Single-Center Pilot Study. Diagnostics. 2026;16(14):2217. doi:10.3390/diagnostics16142217
BibTeX
@article{Tuna2026,
author = {Tuna, Hüseyin Saygin and Reichardt, Benjamin and Kucukay, Fahrettin and Haage, Patrick},
title = {Transarterial Microembolization in Refractory Plantar Fasciitis: Functional and Patient-Reported Early- to Midterm Outcomes from a Single-Center Pilot Study},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {14},
pages = {2217},
doi = {10.3390/diagnostics16142217}
}
EUVIMED